Submitted by Anonymous (not verified) on 13 November 2023 - 10:18
Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Aspergillosis, Date of authorisation: 15/10/2015, Revision: 17, Status: Authorised
Source: